As the spring semester began, a wave of illness spread around the student body. Some chalked it up to colds, others blamed ...

Researchers at Vaxart Inc. and the Center for Vaccine Development at the University of Maryland School of Medicine evaluated ...

WHILE norovirus still circulates at high levels, a new pill designed to protect against the winter vomiting bug has been undergoing trials. Just two weeks ago there was a record number of patients ...

" Signs and symptoms usually begin 12 to 48 hours after your first exposure to a norovirus and last 1 to 3 days," noted the ...

In an early clinical trial, an experimental norovirus vaccine given as a pill produced defensive responses exactly where it counts—in the saliva of older people most vulnerable to the explosive ...

The number of people in hospital in England with norovirus remains at a seasonally high level, new NHS figures show. An ...

There are fears of a second wave of norovirus as cases have surged over the last two week, the UK Health Security Agency has ...

Norovirus is continuing to pile pressure on NHS hospitals with over 40,000 bed days lost to the vomiting bug in February alone. The latest data shows there were 1,094 patients a day in hospital with ...

Norovirus is also hard to kill on surfaces, where it can live for days to weeks. If someone in your household vomits in the ...

Vaxart (VXRT) announced that complete data from the Phase 1b trial of its first-generation oral pill norovirus vaccine candidate in elderly ...

Norovirus has torn through the U.S. this winter, peaking early in some parts of the country but taking hold in South Florida ...

Researchers identify key antibodies that bring us one step closer to treatment and vaccine for norovirus, a prevalent and difficult virus to prevent.